Literature DB >> 24554379

An examination of the inhibitory effects of three antibiotics in combination on ribosome biosynthesis in Staphylococcus aureus.

Justin M Beach1, W Scott Champney.   

Abstract

Although a number of different antibiotics are used to combat staphylococcal infections, resistance has continued to develop. The use of rifampicin and ciprofloxacin in combination with azithromycin, known for its inhibitory effects on the bacterial ribosome, can create potential synergistic effects on ribosomal subunit synthesis rates. In this work, combination antibiotic treatments gave a significant decrease in cell numbers following growth in the presence of ciprofloxacin or rifampicin with azithromycin compared to those grown with azithromycin or rifampicin alone. DNA, RNA and protein synthesis rates were reduced with single antibiotic treatments and showed further decreases when drug combinations were used. 70S ribosome levels were reduced with every antibiotic treatment. DNA gyrase subunits A and B showed significant decreases for double and triple antibiotic-treated samples. Ribosomal subunit synthesis rates were diminished for each different antibiotic combination. Turnover of 16S and 23S rRNA was also observed in each case and was stimulated by antibiotic combinations. The frequency of spontaneous resistance was reduced in all double selections, and no triply resistant mutants were found.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24554379     DOI: 10.1007/s00203-014-0963-5

Source DB:  PubMed          Journal:  Arch Microbiol        ISSN: 0302-8933            Impact factor:   2.552


  2 in total

1.  Macromolecular Structure Assembly as a Novel Antibiotic Target.

Authors:  Scott Champney
Journal:  Antibiotics (Basel)       Date:  2022-07-13

2.  Enhanced Biosynthesis of Fatty Acids Is Associated with the Acquisition of Ciprofloxacin Resistance in Edwardsiella tarda.

Authors:  Yu-Bin Su; Su-Fang Kuang; Jin-Zhou Ye; Jian-Jun Tao; Hui Li; Xuan-Xian Peng; Bo Peng
Journal:  mSystems       Date:  2021-08-24       Impact factor: 6.496

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.